Hepatocellular Carcinoma: Diagnosis and Management

More Information

What kind of information would you like to request?     More Information       Make a Referral

Leave this field empty

In this presentation, Maalouf Hoteit, MD, examines the current state of hepatocellular carcinoma diagnosis, treatment and prevention from the perspective that early screening and treatment of hepatitis C and early treatment of liver cancer holds the greatest promise patients at risk for the disease. Includes a discussion of the PD-1 inhibitor nivolumab, the latest addition to the armamentarium for advanced HCC.

Comments